{"disease":{"id":"proliferative-diabetic-retinopathy-high-risk","name":"proliferative diabetic retinopathy high risk"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06899529","title":"Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy","phase":"NA","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Christian Ophthalmic Surgery Expedition Network","has_results":false},{"nct_id":"NCT06653361","title":"Ultra-Widefield Fluorescein Angiography-Based Targeted Retinal Photocoagulation Versus Conventional Panretinal Photocoagulation in the Preservation of Visual Function and Regression of Proliferative Diabetic Retinopathy","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Hayatabad Medical Complex","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}